165 related articles for article (PubMed ID: 30292665)
1. Hypoxia-Inducible Factor 1α and AT-Rich Interactive Domain-Containing Protein 1A Expression in Pituitary Adenomas: Association with Pathological, Clinical, and Radiological Features.
Kinali B; Senoglu M; Karadag FK; Karadag A; Middlebrooks EH; Oksuz P; Sandal E; Turk C; Diniz G
World Neurosurg; 2019 Jan; 121():e716-e722. PubMed ID: 30292665
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induces hemorrhagic transformation in pituitary adenomas via the HIF-1α signaling pathway.
Xiao Z; Liu Q; Zhao B; Wu J; Lei T
Oncol Rep; 2011 Dec; 26(6):1457-64. PubMed ID: 21822544
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas.
Fowkes RC; Vlotides G
Endocr Relat Cancer; 2012 Feb; 19(1):C1-5. PubMed ID: 22009798
[TBL] [Abstract][Full Text] [Related]
4. Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.
Yoshida D; Kim K; Yamazaki M; Teramoto A
Endocr Pathol; 2005; 16(2):123-31. PubMed ID: 16199897
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.
Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S
Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566
[TBL] [Abstract][Full Text] [Related]
6. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas.
Jin Kim Y; Hyun Kim C; Hwan Cheong J; Min Kim J
Tumori; 2011; 97(5):639-46. PubMed ID: 22158497
[TBL] [Abstract][Full Text] [Related]
7. Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours.
Vidal S; Horvath E; Kovacs K; Kuroki T; Lloyd RV; Scheithauer BW
Histol Histopathol; 2003 Jul; 18(3):679-86. PubMed ID: 12792878
[TBL] [Abstract][Full Text] [Related]
8. Curcumin suppresses HIF1A synthesis and VEGFA release in pituitary adenomas.
Shan B; Schaaf C; Schmidt A; Lucia K; Buchfelder M; Losa M; Kuhlen D; Kreutzer J; Perone MJ; Arzt E; Stalla GK; Renner U
J Endocrinol; 2012 Sep; 214(3):389-98. PubMed ID: 22739211
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlations with clinical variables.
Matsuyama J
Neurol Med Chir (Tokyo); 2012; 52(8):563-9. PubMed ID: 22976139
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
11. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
12. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
13. Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency.
Han N; Kim MA; Lee HS; Kim WH
Appl Immunohistochem Mol Morphol; 2016; 24(5):320-5. PubMed ID: 26067140
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Aggressive Behavior and Invasive Features of Pituitary Adenomas Using Radiological, Surgical, Clinical and Histopathological Markers.
Kucuk A; Bayram F; Ozturk F; Tumturk A; Diri H; Oral S; Tucer B; Durak AC; Kurtsoy A
Turk Neurosurg; 2016; 26(5):671-7. PubMed ID: 27438615
[TBL] [Abstract][Full Text] [Related]
15. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of AT-rich interactive domain 1A in hepatocellular carcinoma.
Abe H; Hayashi A; Kunita A; Sakamoto Y; Hasegawa K; Shibahara J; Kokudo N; Fukayama M
Int J Clin Exp Pathol; 2015; 8(3):2763-70. PubMed ID: 26045782
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
Pan LX; Chen ZP; Liu YS; Zhao JH
J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
[TBL] [Abstract][Full Text] [Related]
20. HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy.
Kun Z; Yuling Y; Dongchun W; Bingbing X; Xiaoli L; Bin X
Technol Cancer Res Treat; 2016 Dec; 15(6):NP95-NP104. PubMed ID: 26647409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
